Top Markets
Coin of the day
IMBdx IMBdx

IMBdx

461030
Rangering i aksjer #27739
IMBdx, Inc. specializes in developing advanced liquid biopsy technologies for... IMBdx, Inc. specializes in developing advanced liquid biopsy technologies for cancer detection and management. The company's core mission revolves around three key areas: facilitating the diagnosis and treatment strategies for advanced-stage cancers, enabling the early identification of cancer recurrence after surgical interventions, and providing solutions for the early diagnosis of cancer. Its notable product offerings include AlphaLiquid, CancerDetect, and CancerFind. The firm was established by Tae-Yu Kim, Sung-Tae Moon, and Doo-Hee Bang on July 5, 2018, and maintains its headquarters in Seoul, South Korea.
Aksjekurs
$2.14
Markedsverdi
$30.63M
Endring (1 dag)
0.16%
Endring (1 år)
-62.09%
Land
KR
Handel IMBdx (461030)

Kategori

Historikk for aksjesplitt for IMBdx (461030)
Aksjen IMBdx (symbol: 461030) har gjennomgått totalt 0 aksjesplitt.
Den nyeste splittelsen skjedde Aug 20, 2026.
Én 461030-aksje kjøpt før Aug 20, 2026 tilsvarer i dag 0 461030-aksjer.
Liste over aksjesplitt
År Splitt Multiplikator Kumulativ multiplikator
Ikke nok data for de angitte datoene.
Aksjesplitt for lignende selskaper eller konkurrenter
Selskap Antall aksjesplitt Kumulativ multiplikator Land
1 x2
US
0 -
US
0 -
NL
1 x3
AU
0 -
CH